CIRM Board Approves New Clinical Trial for Rare Childhood Disease Original article published on the CIRM website, June 20,...
Read moreBy Cystinosis Research Network
June 22, 2019
Genetic testing is now being offered to cystinosis families at a discounted rate. However, you may be wondering, who...
Read moreBy Cystinosis Research Network
June 19, 2019
In order to think of what Cystinosis Awareness Day means to me I had to think about what cystinosis...
Read moreBy Cystinosis Research Network
May 7, 2019
News from Leadiant regarding new storage of Cystaran (cysteamine ophthalmic solution) 0.44%. Beginning December 22, 2025, shipments of Cystaran...
Read moreThe next phase of clinical development for the CF10 prodrug to treat cystinosis has been announced. The Cystinosis Foundation...
Read moreThe Neuromuscular Clinic at Massachusetts General Hospital (MGH) led by Dr. Reza Seyedsadjadi, is currently enrolling participants for a...
Read moreEmory University in Atlanta, Georgia, is actively recruiting for the Cohort 0 control groupin the CYStem clinical trial. While...
Read moreA new chapter in cystinosis research has begun. Novartis has officially opened the next phase of its CYStem Phase...
Read moreFor our families using Cystadrops, we received the following information from Recordati. This update was in response to direct...
Read more